Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report

Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report

We describe the case of a 44-year-old female patient on rituximab for the treatment of multiple sclerosis with undetectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG specific antibodies 18 days after the second dose of SARS-CoV-2 vaccine. Interferon-gamma release assay testing...

Full description

Bibliographic Details
Main Authors:	Jessica Ferguson, Kanagavel Murugesan, Niaz Banaei, Anne Liu
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	International Journal of Infectious Diseases
Subjects:	SARS-CoV-2 SARS-CoV-2 vaccination T cell respone Impaired humoral immunity
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971221005427

Similar Items

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness
by: John A. Lednicky, et al.
Published: (2021-07-01)

In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
by: Shana V. Stoddard, et al.
Published: (2021-07-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
by: Zeinab Abdelrahman, et al.
Published: (2020-09-01)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
by: Francesco Sessa, et al.
Published: (2021-03-01)

Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19
by: Angela Chiereghin, et al.
Published: (2021-02-01)

Nefropatia associata al SARS-CoV-2: cosa sappiamo finora
by: Aris Tsalouchos, et al.
Published: (2020-07-01)

Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV
by: Mingxuan Xie, et al.
Published: (2020-05-01)

How long can SARS-CoV-2 persist in human corpses?
by: Mario Gabbrielli, et al.
Published: (2021-05-01)

Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line
by: Alexander A. Dolskiy, et al.
Published: (2020-12-01)

EMERGENCIA DE SARS-COV-2. ASPECTOS BÁSICOS SOBRE SU ORIGEN, EPIDEMIOLOGÍA, ESTRUCTURA Y PATOGENIA PARA CLÍNICOS
by: Jeannette Dabanch
Published: (2021-01-01)

SARS-CoV-2 RNA detection in cerebrospinal fluid: Presentation of two cases and review of literature
by: María Belén Luis, et al.
Published: (2021-08-01)

The SARS-CoV-2 outbreak from a one health perspective
by: Maged Gomaa Hemida, et al.
Published: (2020-12-01)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
by: Ahmed M. Alluwaimi, et al.
Published: (2020-09-01)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
by: Yanwen Liang, et al.
Published: (2020-05-01)

Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
by: Balasubramanian Ganesh, et al.
Published: (2021-04-01)

Comparison of Immunological Profiles of SARS-CoV-2 Variants in the COVID-19 Pandemic Trends: An Immunoinformatics Approach
by: Jenifer Mallavarpu Ambrose, et al.
Published: (2021-05-01)

Prediction of inhibitory constants of compounds against SARS-CoV 3CLpro enzyme with 2D-QSAR model
by: Xinliang Yu
Published: (2021-07-01)

Identification of MMP-9 as a Driving Factor in SARS-CoV-2 Entry
by: Phan, Alexandra
Published: (2021)

Comparison of Selected Characteristics of SARS-CoV-2, SARS-CoV, and HCoV-NL63
by: Darina Bačenková, et al.
Published: (2021-02-01)

Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2)
by: Nosheen Masood, et al.
Published: (2020-08-01)

Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients
by: Bertram Flehmig, et al.
Published: (2020-11-01)

Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples
by: Richard S. Bennett, et al.
Published: (2021-05-01)

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
by: Ujjwal Neogi, et al.
Published: (2020-04-01)

Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses
by: Nicola Borbone, et al.
Published: (2021-02-01)

Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19
by: Prabhash Kumar Jha, et al.
Published: (2021-01-01)

Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species
by: Sultan Nafea Alharbi, et al.
Published: (2021-03-01)

Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm
by: Mattia Vinciguerra, et al.
Published: (2020-07-01)

Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers
by: Evgenii Shumilov, et al.
Published: (2021-06-01)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
by: Hatem A. Elshabrawy
Published: (2020-06-01)

What Binds Cationic Photosensitizers Better: Brownian Dynamics Reveals Key Interaction Sites on Spike Proteins of SARS-CoV, MERS-CoV, and SARS-CoV-2
by: Vladimir Fedorov, et al.
Published: (2021-08-01)

Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model
by: Sahar Alsaidi, et al.
Published: (2021-07-01)

Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved
by: Xiaorong Wang, et al.
Published: (2020-06-01)

Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
by: Irina Leneva, et al.
Published: (2021-08-01)

Pulmonary involvement and cytochemical storm: beyond SARS-CoV-2 pneumoniae
by: Ombretta Para, et al.
Published: (2020-12-01)

Eye Infection with SARS-CoV-2 as a Route to Systemic Immunization?
by: Blomet, J., et al.
Published: (2022)

Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants
by: Alice Massacci, et al.
Published: (2020-12-01)